Population Analysis of Myelosuppression Profiles Using Routine Clinical Data after the ICE (Ifosfamide/ Carboplatin/Etoposide) Regimen for Malignant Gliomas
- Author
- YANO, Yoshitaka1 ; KODAWARA, Takaaki2 ; HONGO, Haruyuki2 ; YANO, Ikuko2 ; KISHI, Y. O3 ; TAKAHASHI, Jun3 ; INUI, Ken-Ichi2
[1] Center for Integrative Education of Pharmacy Frontier, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Shimoadachi-cho, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan
[2] Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan
[3] Department of Neurosurgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan - Source
Journal of pharmaceutical sciences. 2009, Vol 98, Num 11, pp 4402-4412, 11 p ; ref : 32 ref
- CODEN
- JPMSAE
- ISSN
- 0022-3549
- Scientific domain
- Pharmacology drugs
- Publisher
- American Pharmaceutical Association, Washington, DC
/
Wiley, Hoboken, NJ
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- ICE cancer chemotherapy erlang distribution modeling and simulation myelosuppresion pharmacodynamics population analysis
- Keyword (fr)
- Activité biologique Anticancéreux Carboplatine Chimiothérapie Distribution Etoposide Gliome malin Ifosfamide Modélisation Simulation Technologie pharmaceutique Tumeur maligne Agent alkylant Antimitotique Cancer DNA topoisomerase (ATP-hydrolysing) Dérivé de l'oxazaphosphinane Dérivé de la podophyllotoxine Enzyme Inhibiteur de la topoisomérase II Inhibiteur enzyme Isomerases Moutarde à l'azote Pathologie du système nerveux central Pathologie du système nerveux Pharmacocinétique Platine II Complexe Traitement
- Keyword (en)
- Biological activity Antineoplastic agent Carboplatin Chemotherapy Distribution Etoposide Malignant glioma Ifosfamide Modeling Simulation Pharmaceutical technology Malignant tumor Alkylating agent Antimitotic Cancer DNA topoisomerase (ATP-hydrolysing) Oxazaphosphinane derivatives Podophyllotoxin derivatives Enzyme Topoisomerase II inhibitor Enzyme inhibitor Isomerases Nitrogen mustard Central nervous system disease Nervous system diseases Pharmacokinetics Platinum II Complexes Treatment
- Keyword (es)
- Actividad biológica Anticanceroso Carboplatino Quimioterapia Distribución Etopósido Glioma maligno Ifosfamida Modelización Simulación Tecnología farmacéutica Tumor maligno Agente alquilante Antimitótico Cáncer DNA topoisomerase (ATP-hydrolysing) Oxazafosfinano derivado Podofilotoxina derivado Enzima Inhibidor topoisomerase II Inhibidor enzima Isomerases Mostaza al nitrógeno Sistema nervosio central patología Sistema nervioso patología Farmacocinética Platino II Complejo Tratamiento
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02A General pharmacology / 002B02A03 Pharmaceutical technology. Pharmaceutical industry
- Discipline
- General pharmacology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 22139613
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1002/jps.21731 
https://dx.doi.org/10.1002/jps.21731
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/jps.21731\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:156:\"Population Analysis of Myelosuppression Profiles Using Routine Clinical Data after the ICE (Ifosfamide\/ Carboplatin\/Etoposide) Regimen for Malignant Gliomas\";s:9:\"\u0000*\u0000jtitle\";s:34:\"Journal of pharmaceutical sciences\";s:9:\"\u0000*\u0000stitle\";s:13:\"J. pharm. sci\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"98\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"4402\";s:8:\"\u0000*\u0000epage\";s:4:\"4412\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-3549\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"YANO\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Yoshitaka\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:17:\"KODAWARA, Takaaki\";i:1;s:15:\"HONGO, Haruyuki\";i:2;s:11:\"YANO, Ikuko\";i:3;s:11:\"KISHI, Y. O\";i:4;s:14:\"TAKAHASHI, Jun\";i:5;s:14:\"INUI, Ken-Ichi\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JPMSAE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:156:\"Population Analysis of Myelosuppression Profiles Using Routine Clinical Data after the ICE (Ifosfamide\/ Carboplatin\/Etoposide) Regimen for Malignant Gliomas\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"American Pharmaceutical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/jps.21731\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:156:\"Population Analysis of Myelosuppression Profiles Using Routine Clinical Data after the ICE (Ifosfamide\/ Carboplatin\/Etoposide) Regimen for Malignant Gliomas\";s:9:\"\u0000*\u0000jtitle\";s:34:\"Journal of pharmaceutical sciences\";s:9:\"\u0000*\u0000stitle\";s:13:\"J. pharm. sci\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"98\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"4402\";s:8:\"\u0000*\u0000epage\";s:4:\"4412\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-3549\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"YANO\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Yoshitaka\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:17:\"KODAWARA, Takaaki\";i:1;s:15:\"HONGO, Haruyuki\";i:2;s:11:\"YANO, Ikuko\";i:3;s:11:\"KISHI, Y. O\";i:4;s:14:\"TAKAHASHI, Jun\";i:5;s:14:\"INUI, Ken-Ichi\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JPMSAE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:156:\"Population Analysis of Myelosuppression Profiles Using Routine Clinical Data after the ICE (Ifosfamide\/ Carboplatin\/Etoposide) Regimen for Malignant Gliomas\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"American Pharmaceutical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/jps.21731\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/jps.21731\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:156:\"Population Analysis of Myelosuppression Profiles Using Routine Clinical Data after the ICE (Ifosfamide\/ Carboplatin\/Etoposide) Regimen for Malignant Gliomas\";s:9:\"\u0000*\u0000jtitle\";s:34:\"Journal of pharmaceutical sciences\";s:9:\"\u0000*\u0000stitle\";s:13:\"J. pharm. sci\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"98\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"4402\";s:8:\"\u0000*\u0000epage\";s:4:\"4412\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-3549\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"YANO\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Yoshitaka\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:17:\"KODAWARA, Takaaki\";i:1;s:15:\"HONGO, Haruyuki\";i:2;s:11:\"YANO, Ikuko\";i:3;s:11:\"KISHI, Y. O\";i:4;s:14:\"TAKAHASHI, Jun\";i:5;s:14:\"INUI, Ken-Ichi\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JPMSAE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:156:\"Population Analysis of Myelosuppression Profiles Using Routine Clinical Data after the ICE (Ifosfamide\/ Carboplatin\/Etoposide) Regimen for Malignant Gliomas\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"American Pharmaceutical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/jps.21731\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:156:\"Population Analysis of Myelosuppression Profiles Using Routine Clinical Data after the ICE (Ifosfamide\/ Carboplatin\/Etoposide) Regimen for Malignant Gliomas\";s:9:\"\u0000*\u0000jtitle\";s:34:\"Journal of pharmaceutical sciences\";s:9:\"\u0000*\u0000stitle\";s:13:\"J. pharm. sci\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"98\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"4402\";s:8:\"\u0000*\u0000epage\";s:4:\"4412\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-3549\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"YANO\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Yoshitaka\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:17:\"KODAWARA, Takaaki\";i:1;s:15:\"HONGO, Haruyuki\";i:2;s:11:\"YANO, Ikuko\";i:3;s:11:\"KISHI, Y. O\";i:4;s:14:\"TAKAHASHI, Jun\";i:5;s:14:\"INUI, Ken-Ichi\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JPMSAE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:156:\"Population Analysis of Myelosuppression Profiles Using Routine Clinical Data after the ICE (Ifosfamide\/ Carboplatin\/Etoposide) Regimen for Malignant Gliomas\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"American Pharmaceutical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1002\/jps.21731\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:156:\"Population Analysis of Myelosuppression Profiles Using Routine Clinical Data after the ICE (Ifosfamide\/ Carboplatin\/Etoposide) Regimen for Malignant Gliomas\";s:9:\"\u0000*\u0000jtitle\";s:34:\"Journal of pharmaceutical sciences\";s:9:\"\u0000*\u0000stitle\";s:13:\"J. pharm. sci\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"98\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"4402\";s:8:\"\u0000*\u0000epage\";s:4:\"4412\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-3549\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"YANO\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Yoshitaka\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:17:\"KODAWARA, Takaaki\";i:1;s:15:\"HONGO, Haruyuki\";i:2;s:11:\"YANO, Ikuko\";i:3;s:11:\"KISHI, Y. O\";i:4;s:14:\"TAKAHASHI, Jun\";i:5;s:14:\"INUI, Ken-Ichi\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JPMSAE\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:156:\"Population Analysis of Myelosuppression Profiles Using Routine Clinical Data after the ICE (Ifosfamide\/ Carboplatin\/Etoposide) Regimen for Malignant Gliomas\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"American Pharmaceutical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
